The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 26, 2013

Filed:

Jan. 19, 2011
Applicants:

Sarah Teter, Mountain View, CA (US);

Connie Ward, Hamilton, MO (US);

Joel Cherry, Winters, CA (US);

Aubrey Jones, Davis, CA (US);

Paul Harris, Carnation, WA (US);

Jung Yi, Sacramento, CA (US);

Inventors:

Sarah Teter, Mountain View, CA (US);

Connie Ward, Hamilton, MO (US);

Joel Cherry, Winters, CA (US);

Aubrey Jones, Davis, CA (US);

Paul Harris, Carnation, WA (US);

Jung Yi, Sacramento, CA (US);

Assignee:

Novozymes, Inc., Davis, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 9/42 (2006.01); C12S 3/00 (2006.01); C12S 3/02 (2006.01); C12P 19/14 (2006.01); C11D 3/386 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention relates to variants of a parent glycoside hydrolase, comprising a substitution at one or more positions corresponding to positions 21, 94, 157, 205, 206, 247, 337, 350, 373, 383, 438, 455, 467, and 486 of amino acids 1 to 513 of SEQ ID NO: 2, and optionally further comprising a substitution at one or more positions corresponding to positions 8, 22, 41, 49, 57, 113, 193, 196, 226, 227, 246, 251, 255, 259, 301, 356, 371, 411, and 462 of amino acids 1 to 513 of SEQ ID NO: 2 a substitution at one or more positions corresponding to positions 8, 22, 41, 49, 57, 113, 193, 196, 226, 227, 246, 251, 255, 259, 301, 356, 371, 411, and 462 of amino acids 1 to 513 of SEQ ID NO: 2, wherein the variants have glycoside hydrolase activity. The present invention also relates to nucleotide sequences encoding the variant glycoside hydrolases and to nucleic acid constructs, vectors, and host cells comprising the nucleotide sequences.


Find Patent Forward Citations

Loading…